Take Solutions Limited (TAKE) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.122x

Based on the latest financial reports, Take Solutions Limited (TAKE) has a cash flow conversion efficiency ratio of -0.122x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-31.39 Million ≈ $-339.47K USD) by net assets (Rs256.29 Million ≈ $2.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see TAKE market cap overview for the company's overall valuation and market capitalisation.

Take Solutions Limited - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Take Solutions Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Take Solutions Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Take Solutions Limited ranked by their cash flow conversion efficiency. Explore how high is Take Solutions Limited's earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Scandinavian Investment Group A/S
CO:SIG
0.046x
Wemade Max Co. Ltd
KQ:101730
-0.016x
Seoyon Topmetal Co. Ltd
KQ:019770
0.081x
A SPAC III Acquisition Corp. Class A Ordinary Shares
NASDAQ:ASPC
-0.056x
Hyrican Informationssysteme Aktiengesellschaft
F:HYI
N/A
Orion Digital Corp.
TO:ORIO
0.051x
QPM Energy Ltd
AU:QPM
-0.108x
Hultström Group B
ST:HULT-B
0.112x

Annual Cash Flow Conversion Efficiency for Take Solutions Limited (2007–2025)

The table below shows the annual cash flow conversion efficiency of Take Solutions Limited from 2007 to 2025. View Take Solutions Limited stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs205.27 Million
≈ $2.22 Million
Rs-163.66 Million
≈ $-1.77 Million
-0.797x +24.06%
2024-03-31 Rs-88.73 Million
≈ $-959.58K
Rs93.16 Million
≈ $1.01 Million
-1.050x -669.68%
2023-03-31 Rs1.09 Billion
≈ $11.74 Million
Rs200.16 Million
≈ $2.16 Million
0.184x +12.40%
2022-03-31 Rs1.81 Billion
≈ $19.53 Million
Rs296.17 Million
≈ $3.20 Million
0.164x +36.32%
2021-03-31 Rs11.24 Billion
≈ $121.59 Million
Rs1.35 Billion
≈ $14.63 Million
0.120x -9.68%
2020-03-31 Rs15.85 Billion
≈ $171.45 Million
Rs2.11 Billion
≈ $22.83 Million
0.133x +96.40%
2019-03-31 Rs15.27 Billion
≈ $165.18 Million
Rs1.04 Billion
≈ $11.20 Million
0.068x -25.00%
2018-03-31 Rs13.37 Billion
≈ $144.56 Million
Rs1.21 Billion
≈ $13.07 Million
0.090x +54.17%
2017-03-31 Rs9.53 Billion
≈ $103.08 Million
Rs558.98 Million
≈ $6.05 Million
0.059x -73.41%
2016-03-31 Rs6.72 Billion
≈ $72.62 Million
Rs1.48 Billion
≈ $16.02 Million
0.221x +72.74%
2015-03-31 Rs5.80 Billion
≈ $62.78 Million
Rs741.25 Million
≈ $8.02 Million
0.128x -33.69%
2014-03-31 Rs5.18 Billion
≈ $56.06 Million
Rs998.25 Million
≈ $10.80 Million
0.193x -23.03%
2013-03-31 Rs4.66 Billion
≈ $50.41 Million
Rs1.17 Billion
≈ $12.61 Million
0.250x -17.75%
2012-03-31 Rs3.80 Billion
≈ $41.05 Million
Rs1.15 Billion
≈ $12.49 Million
0.304x +45.36%
2011-03-31 Rs2.82 Billion
≈ $30.48 Million
Rs589.85 Million
≈ $6.38 Million
0.209x +341.83%
2010-03-31 Rs3.86 Billion
≈ $41.70 Million
Rs182.63 Million
≈ $1.98 Million
0.047x -72.58%
2009-03-31 Rs3.86 Billion
≈ $41.73 Million
Rs666.62 Million
≈ $7.21 Million
0.173x +1.88%
2008-03-31 Rs2.98 Billion
≈ $32.28 Million
Rs506.13 Million
≈ $5.47 Million
0.170x +25.11%
2007-03-31 Rs885.44 Million
≈ $9.58 Million
Rs120.02 Million
≈ $1.30 Million
0.136x --

About Take Solutions Limited

NSE:TAKE India Biotechnology
Market Cap
$25.24 Million
Rs2.33 Billion INR
Market Cap Rank
#24442 Global
#1347 in India
Share Price
Rs15.96
Change (1 day)
-4.94%
52-Week Range
Rs10.37 - Rs50.14
All Time High
Rs293.99
About

TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services in life sciences and software and information technology in India. The company offers clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance and safety services backed by technology expertise. It also provides embed digital and employ mobile solutions for patient c… Read more